Analyst Ratings for BioMimetic Therapeutics (BMTI) [Buys]
BMTI Rating Summary
BMTI Price Target Summary
- Highest: $13.00 (Canaccord Genuity)
- Lowest: $7.00 (Collins Stewart)
- Average: $10.00
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$10.00 (+5.4%)
Avg. $ Target:
$10.00 (+5.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/22/2011 | Collins Stewart » Updated 2/7/2012 |
New Coverage | Buy (N/A) |
7.00 (N/A) |
2.88 | 9.49 | 229.51% | Details |
